Zhuangyao Xiaotong Ye (壮腰消痛液)壮腰消痛液

This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。

Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。

生产企业Manufacturer

主要成分Active Ingredients

药物知识说明

枸杞子是一种在国家药监局注册认定的药品。该药品含有乌梅、地龙、威灵仙-2183e113等成分。

该药品关联的活性成分包括:乌梅Wu Mei、地龙Di Long、威灵仙Weiling Xian、巴戟天Baji Tian、木瓜Mu Gua。这些成分信息来自国家药监局数据库。

该药品标注的生产企业为:吉林敖东集团力源制药股份有限公司Chinese legal name: 吉林敖东集团力源制药股份有限公司。

您可以探索含有相同成分的其他药品:乌梅-a8c74dfb成分药品。

本页面内容来自国家药监局数据库,MedicineGraph在此基础上提供关系图谱和知识导航。

Medicine Knowledge

This medicine (original name: 壮腰消痛液) is a medicine registered with the national drug regulatory authority. It contains recorded ingredients as active ingredient(s).

Active ingredients associated with this product: 乌梅Wu Mei, 地龙Di Long, 威灵仙Weiling Xian, 巴戟天Baji Tian, 木瓜Mu Gua.

Manufacturers recorded for this product: 吉林敖东集团力源制药股份有限公司Chinese legal name: 吉林敖东集团力源制药股份有限公司.

Explore other medicines containing the same ingredient: 乌梅 productsProducts containing this recorded ingredient.

Source: MedicineGraph authoritative database. Relationships derived from registered product information.

这是什么What is this

  • 通用名/品名Recorded product name: 壮腰消痛液Recorded Chinese name: 壮腰消痛液
  • 规格Specification: 每瓶装100ml;每瓶装150ml;每瓶装300ml;每瓶装450ml100 mL per bottle;150 mL per bottle;300 mL per bottle;450 mL per bottle

本段仅展示注册/说明书已记录的身份属性,不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.

主要成分Ingredients

生产企业Manufacturer

  • 吉林敖东集团力源制药股份有限公司Chinese legal name: 吉林敖东集团力源制药股份有限公司

注册信息NMPA approval number

  • 批准文号NMPA approval number: 国药准字Z22021219

信息来源Source and scope

国家药品监督管理局(中国)药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.

  • 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
  • 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)

范围:当前 MedicineGraph 注册记录及已记录的精确关系;非完整目录,亦不构成疗效等同主张,也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.

本段为已核准说明书原文摘录(非改写、非AI摘要),非正式英文标签,亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.

English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.

NMPA approval number

国药准字Z22021219

Manufacturer

Chinese legal name: 吉林敖东集团力源制药股份有限公司 (domestically manufactured)

Traditional functions

English translation unavailable. The original Chinese source label remains available below.

Dosage and administration

English translation unavailable. The original Chinese source label remains available below.

Adverse reactions

English translation unavailable. The original Chinese source label remains available below.

Contraindications

English translation unavailable. The original Chinese source label remains available below.

Storage

English translation unavailable. The original Chinese source label remains available below.

Specification

English translation unavailable. The original Chinese source label remains available below.

中文说明书原文Original Chinese source label

批准文号

国药准字Z22021219

生产企业

吉林敖东集团力源制药股份有限公司(国产)

功能主治

壮腰益肾,疏风祛湿,活络止痛。用于肾虚腰痛,风湿骨质增生引起的疼痛。

用法用量

口服,一次20~30毫升(请用量杯量取),一日3次。

不良反应

尚不明确。

禁忌

孕妇忌服,儿童禁用。

贮藏

密封,置阴凉处(不超过20℃)。

规格

每瓶装100ml;每瓶装150ml;每瓶装300ml;每瓶装450ml

证据Evidence

  • 批准文号: 国药准字Z22021219
  • rights: 本段为已核准说明书原文摘录(非改写、非AI摘要),非正式英文标签,亦不构成用药建议。

信息来源Source and scope

国家药品监督管理局(中国)药品注册数据。National Medical Products Administration (China) medicine-registration data.

范围:当前 MedicineGraph 注册记录及已记录的精确关系;非完整目录,亦不构成疗效等同主张,也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.